{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:07:53Z","timestamp":1793905673917,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021524","name":"School of Life Sciences and Biotechnology Division of Life Sciences, Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000741","name":"University of Warwick","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["766124"],"award-info":[{"award-number":["766124"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neuropharm.2023.109647","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T03:51:12Z","timestamp":1689565872000},"page":"109647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antagonism of P2X7 receptors enhances lorazepam action in delaying seizure onset in an in vitro model of status epilepticus."],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-2657","authenticated-orcid":false,"given":"Monica","family":"Garcia-Durillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-3172","authenticated-orcid":false,"given":"Bruno G.","family":"Frenguelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109647_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002508","article-title":"Neuronal hyperactivity disturbs ATP microgradients, impairs microglial motility, and reduces phagocytic receptor expression triggering apoptosis\/microglial phagocytosis uncoupling","volume":"14","author":"Abiega","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-0716-2384-8_21","article-title":"Analyzing the role of the P2X7 receptor in epilepsy","volume":"2510","author":"Alves","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib3","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.1820-08.2008","article-title":"Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling","volume":"28","author":"Avignone","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0304-3940(88)90039-0","article-title":"4-Aminopyridine induces a long-lasting depolarizing GABA-ergic potential in human neocortical and hippocampal neurons maintained in vitro","volume":"94","author":"Avoli","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109647_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2004.04.015","article-title":"Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy","volume":"47","author":"Avsar","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/epi.13263","article-title":"Up-regulation of P2X7 receptor-mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex","volume":"57","author":"Barros-Barbosa","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109647_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102105","article-title":"ATP and adenosine-Two players in the control of seizures and epilepsy development","volume":"204","author":"Beamer","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib8","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/bph.15785","article-title":"Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice","volume":"179","author":"Beamer","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","article-title":"Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus","volume":"18","author":"Burman","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib10","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/brain\/awz283","article-title":"Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus","volume":"142","author":"Burman","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2023.109647_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.seizure.2019.10.006","article-title":"Medical management of status epilepticus: emergency room to intensive care unit","volume":"75","author":"Crawshaw","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109647_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113032","article-title":"GABA(A) receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assays","volume":"23","author":"Crocetti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/157015909789152146","article-title":"Release of adenosine and ATP during ischemia and epilepsy","volume":"7","author":"Dale","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"Suppl. 9","key":"10.1016\/j.neuropharm.2023.109647_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109647_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fnins.2020.00414","article-title":"The role of NMDA receptors in the effect of purinergic P2X7 receptor on spontaneous seizure activity in WAG\/Rij rats with genetic absence epilepsy","volume":"14","author":"Dogan","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2008.10.008","article-title":"Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine","volume":"83","author":"Dona","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib19","doi-asserted-by":"crossref","first-page":"eaar3796","DOI":"10.1126\/scitranslmed.aar3796","article-title":"Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy","volume":"10","author":"Dossi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2023.109647_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00227083","article-title":"Regional and time dependent variations of low Mg2+ induced epileptiform activity in rat temporal cortex slices","volume":"87","author":"Dreier","year":"1991","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2044.1978.tb08271.x","article-title":"Plasma lorazepam levels. A study following single dose administration of 2 and 4 mg by different routes","volume":"33","author":"Dundee","year":"1978","journal-title":"Anaesthesia"},{"key":"10.1016\/j.neuropharm.2023.109647_bib22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2023.109647_bib23","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2147\/JIR.S287740","article-title":"Targeting neuroinflammation via purinergic P2 receptors for disease modification in drug-refractory epilepsy","volume":"14","author":"Engel","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib24","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.0953-816X.2004.03355.x","article-title":"Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner","volume":"19","author":"Etherington","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib25","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1038\/srep06824","article-title":"Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1beta release","volume":"4","author":"Facci","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109647_bib26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-018-1205-6","article-title":"Serum amyloid A primes microglia for ATP-dependent interleukin-1beta release","volume":"15","author":"Facci","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2023.109647_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156468","article-title":"Critical evaluation of P2X7 receptor antagonists in selected seizure models","volume":"11","author":"Fischer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109647_bib28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1471-4159.2006.04425.x","article-title":"Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus","volume":"101","author":"Frenguelli","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109647_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","article-title":"Timing in the treatment of status epilepticus: from basics to the clinic","volume":"68","author":"Gainza-Lein","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109647_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus","volume":"75","author":"Gainza-Lein","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-3806(95)00069-P","article-title":"Properties of low Mg2+ induced epileptiform activity in rat hippocampal and entorhinal cortex slices during adolescence","volume":"87","author":"Gloveli","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/acn3.259","article-title":"Diazepam effect during early neonatal development correlates with neuronal Cl-","volume":"2","author":"Glykys","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2016.11.022","article-title":"Drug development for refractory epilepsy: the past 25 years and beyond","volume":"44","author":"Golyala","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109647_bib34","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABAA receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib35","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01059736","article-title":"Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation","volume":"7","author":"Greenblatt","year":"1979","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.neuropharm.2023.109647_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jps.2600680119","article-title":"Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans","volume":"68","author":"Greenblatt","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.neuropharm.2023.109647_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.910662","article-title":"Mesial temporal lobe epilepsy (MTLE) drug-refractoriness is associated with P2X7 receptors overexpression in the human Hippocampus and temporal neocortex and may Be predicted by low circulating levels of miR-22","volume":"16","author":"Guerra Leal","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/jnc.14543","article-title":"The combination of ribose and adenine promotes adenosine release and attenuates the intensity and frequency of epileptiform activity in hippocampal slices: evidence for the rapid depletion of cellular ATP during electrographic seizures","volume":"147","author":"Hall","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109647_bib40","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-[(cyanoimino)(5-quinolinylamino) methyl]amino-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109647_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12031-017-0968-z","article-title":"Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat Hippocampus","volume":"63","author":"Huang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/srep17486","article-title":"microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus","volume":"5","author":"Jimenez-Mateos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109647_bib43","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/epi.12257","article-title":"Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079","volume":"54","author":"Jimenez-Pacheco","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109647_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2023.109647_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainresbull.2018.07.016","article-title":"Astrocytic rather than neuronal P2X7 receptors modulate the function of the tri-synaptic network in the rodent hippocampus","volume":"151","author":"Khan","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2023.109647_bib47","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1172\/JCI44818","article-title":"The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice","volume":"121","author":"Kim","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109647_bib48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1528-1167.2012.03724.x","article-title":"Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats","volume":"53","author":"Klaft","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2023.109647_bib49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2023.109647_bib50","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4103\/1673-5374.257510","article-title":"P2X7 receptor signaling during adult hippocampal neurogenesis","volume":"14","author":"Leeson","year":"2019","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib51","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/stem.2894","article-title":"P2X7 receptors regulate phagocytosis and proliferation in adult hippocampal and SVZ neural progenitor cells: implications for inflammation in neurogenesis","volume":"36","author":"Leeson","year":"2018","journal-title":"Stem Cell."},{"key":"10.1016\/j.neuropharm.2023.109647_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine release, metabolism, and signaling in the inflammatory response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2011.02.011","article-title":"Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: evidence from purine biosensors and P2 receptor agonists and antagonists","volume":"61","author":"Lopat\u00e1\u0159","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2015.01.014","article-title":"Pannexin-1-mediated ATP release from area CA3 drives mGlu5-dependent neuronal oscillations","volume":"93","author":"Lopat\u00e1\u0159","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib55","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs","volume":"42","author":"Loscher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-3476(05)80925-4","article-title":"Pharmacokinetics of lorazepam in critically ill neonates with seizures","volume":"120","author":"McDermott","year":"1992","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2023.109647_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2013.05.017","article-title":"P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone","volume":"73","author":"Messemer","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib58","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12264-020-00573-9","article-title":"Characterization of the expression of the ATP-gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse","volume":"36","author":"Morgan","year":"2020","journal-title":"Neurosci. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109647_bib59","first-page":"S35","article-title":"In the fast lane: receptor trafficking during status epilepticus","volume":"8","author":"Naylor","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.neuropharm.2023.109647_bib60","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib61","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1345\/aph.1A328","article-title":"Safety of benzodiazepines in newborns","volume":"36","author":"Ng","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2023.109647_bib62","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1007\/s11064-017-2348-z","article-title":"Evaluation of the anticonvulsant effect of brilliant blue G, a selective P2X7 receptor antagonist, in the iv PTZ-, maximal electroshock-, and 6 Hz-induced seizure tests in mice","volume":"42","author":"Nieoczym","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.1980.tb01778.x","article-title":"Entry of lorazepam into cerebrospinal fluid","volume":"10","author":"Ochs","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084755","article-title":"New in vitro phenotypic assay for epilepsy: fluorescent measurement of synchronized neuronal calcium oscillations","volume":"9","author":"Pacico","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109647_bib65","doi-asserted-by":"crossref","first-page":"14012","DOI":"10.1523\/JNEUROSCI.4390-07.2007","article-title":"Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy","volume":"27","author":"Pathak","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib66","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1523\/JNEUROSCI.2765-19.2020","article-title":"Experience recruits MSK1 to expand the dynamic range of synapses and enhance cognition","volume":"40","author":"Privitera","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76428-0","article-title":"Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model","volume":"10","author":"Ramirez-Fernandez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109647_bib68","first-page":"71","article-title":"An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat. Bioinforma Biomath."},{"key":"10.1016\/j.neuropharm.2023.109647_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainres.2006.03.040","article-title":"P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain","volume":"1089","author":"Rappold","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109647_bib70","first-page":"3568","article-title":"Pilocarpine-induced status epilepticus increases the sensitivity of P2X7 and P2Y1 receptors to nucleotides at neural progenitor cells of the juvenile rodent Hippocampus","volume":"27","author":"Rozmer","year":"2017","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2023.109647_bib71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2005.06.047","article-title":"Low tolerance and dependence liabilities of etizolam: molecular, functional, and pharmacological correlates","volume":"519","author":"Sanna","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib72","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuropharm.2011.09.024","article-title":"Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations","volume":"62","author":"Schulz","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib73","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/jn.00620.2001","article-title":"Morphological and electrophysiological evidence for an ionotropic GABA receptor of novel pharmacology","volume":"87","author":"Shen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib74","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuropharm.2005.04.026","article-title":"Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects","volume":"49","author":"Shen","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109647_bib75","first-page":"5433","article-title":"Increased expression of the P2X7 receptor in temporal lobe epilepsy: animal models and clinical evidence","volume":"19","author":"Song","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2023.109647_bib76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yebeh.2015.04.056","article-title":"Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats","volume":"48","author":"Soni","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2023.109647_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.seizure.2020.08.011","article-title":"Institutional pediatric convulsive status epilepticus protocol decreases time to first and second line anti-seizure medication administration","volume":"81","author":"Trau","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2023.109647_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijms23010042","article-title":"High-dose benzodiazepines positively modulate GABA(A) receptors via a flumazenil-insensitive mechanism","volume":"23","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109647_bib79","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0306-4522(94)90032-9","article-title":"Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms","volume":"58","author":"Young","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109647_bib80","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1152\/jn.00891.2012","article-title":"Status epilepticus enhances tonic GABA currents and depolarizes GABA reversal potential in dentate fast-spiking basket cells","volume":"109","author":"Yu","year":"2013","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109647_bib81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2023.05.012","article-title":"P2X7 receptor in microglia contributes to propofol-induced unconsciousness by regulating synaptic plasticity in mice","volume":"523","author":"Zhang","year":"2023","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082300237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:41Z","timestamp":1758439481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082300237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":81,"alternative-id":["S002839082300237X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109647","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of P2X7 receptors enhances lorazepam action in delaying seizure onset in an in vitro model of status epilepticus.","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109647"}}